Method and device for treatment of respiratory tract disorders

• US 20030234198A1
• Filed: 06/11/2003
• Published: 12/25/2003
• Est. Priority Date: 06/19/2002
• Status: Active Grant

• Current Assignee: Pharmaceutical Design, LLC
• Original Assignee: Allan M. Weinstein, Robert E. Weinstein
• Inventors: Weinstein, Robert E., Weinstein, Allan M.
• Granted Patent: US 7,156,089 B2
• Time in Patent Office: Days
• US Class Current: 206/438
• CPC Class Codes: A61K 9/0075 for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
• CPC Class Codes: A61M 15/0068 Indicating or counting the number of dispensed doses or of remaining doses
• CPC Class Codes: A61M 15/009 using medicine packages with incorporated spraying means, e.g. aerosol cans pocket atomiser of the injector type A61M11/08
• CPC Class Codes: A61M 2209/06 Packaging for specific medical equipment

Abstract

An organizational treatment device and method for the treatment of obstructive pulmonary disease comprising both controller and rescue medications such that the need for rescue medication and consequent need for controller medication can be more certainly determined than at present.

Claims

1. A prepackaged therapeutic system comprising:

multiple dosages of at least one respiratory controller agent;

multiple dosages of at least one respiratory rescue agent in an aerosol delivery device;

indicia for distinguishing said at least one controller agent and said at least one rescue agent;

instructions for using said at least one controller agent and said at least one rescue agent together as a therapeutic regimen and for alerting the user to monitor over-dependence on rescue medication; and

a unifying container containing said at least one respiratory controller agent, said at least one respiratory rescue agent, said indicia, and said instructions.

2. The system of claim 1 wherein said instructions further indicate that a user'"'"'s requirement for rescue agent is a determinant for controller medication requirements.

3. The system of claim 1 further comprising an actuation monitor configured to monitor the number of times said at least one rescue agent is used.

4. The system of claim 3 wherein said actuation monitor is a separate monitor adapted for use with said aerosol delivery device of said rescue agent.

5. The system of claim 3 wherein said actuation monitor is integrally connected to said aerosol delivery device of said rescue agent.

6. The system of claim 1 wherein said at least one controller agent is selected from the group consisting of inhaled corticosteroids, long-acting bronchodilators, and leukotriene modifiers.

7. The system of claim 1 wherein said at least one rescue medication is albuterol.

8. A therapeutic method comprising:

manufacturing a unifying container that contains multiple dosages of at least one respiratory controller agent, multiple dosages of at least one aerosol respiratory rescue agent, and indicia for distinguishing said at least one controller agent and said at least one rescue agent;

devising instructions for using said at least one controller agent and said at least one rescue agent as a treatment regime and for alerting a user to monitor over-dependence on said at least one rescue agent; and

incorporating said instructions within said unifying container.

9. The method of claim 8 wherein said manufacturing step further includes indicating in said instructions that said user'"'"'s requirement for rescue agent is a determinant for controller medication requirement.

10. The method of claim 8 wherein said manufacturing step further includes providing an actuation monitor configured to monitor the number of times said at least one rescue agent is used.

11. A therapeutic method comprising:

prescribing a prepackaged unifying container that contains multiple dosages of at least one respiratory controller agent, multiple dosages of at least one aerosol respiratory rescue agent, indicia for distinguishing between said controller agent and said rescue agent, and instructions for using said at least one controller agent and said at least one rescue agent as a treatment regime and for alerting a user to monitor over-dependence on said rescue medication; and

adjusting controller agent utilization in accord with utilization of said rescue medication.

12. The method of claim 11 wherein said prescribing step further includes providing an actuation monitor configured to monitor the number of times said at least one rescue agent is used.

13. A therapeutic method comprising:

obtaining a prepackaged unifying container that contains multiple dosages of at least one respiratory controller agent, multiple dosages of at least one aerosol respiratory rescue agent, indicia for distinguishing said controller agent and said rescue agent, and instructions for using said at least one controller agent and said at least one rescue agent as a treatment regime and for alerting a user to monitor over-dependence on rescue medication;

assessing the requirements for rescue medication; and

adjusting controller agent utilization in accord with rescue medication requirements with the advice of a caregiver.

14. The method of claim 13 wherein said obtaining step further includes providing instructions that indicate that said user'"'"'s requirement of rescue agent is a determinant for controller medication requirement.

15. The method of claim 13 wherein said obtaining step further includes obtaining an actuation monitor configured to monitor the number of times said at least one rescue agent is used.

16. A therapeutic method comprising:

dispensing a unifying container that contains multiple dosages of at least one respiratory controller agent, multiple dosages of at least one aerosol respiratory rescue agent, indicia for distinguishing said controller agent and said rescue agent, and instructions for using said at least one controller agent and said at least one rescue agent as a treatment regime and for alerting a user to monitor over-dependence on rescue medication.

17. The method of claim 16 wherein said dispensing step further includes instructions indicating that a user'"'"'s requirement for said rescue agent is a determinant for controller medication requirement.

18. The method of claim 16 wherein said dispensing step further includes dispensing an actuation monitor configured to monitor the number of times said at least one rescue agent is used.

19. A prepackaged therapeutic device for reducing medication error and side-effects in the use of combined controller and rescue treatments for obstructive respiratory disorders, said device comprising:

respiratory controller means for providing a long-term controller medication;

respiratory rescue means for providing a fast-acting rescue medication;

indicia means for distinguishing said controller means from said rescue means;

instruction means for coordinating the use of said controller means and said rescue means as a treatment regime and for alerting a user to monitor over-dependence on rescue medication; and

container means for unifying said controller means, said rescue means, said instruction means, and said indicia means.

20. The device of claim 19 further including actuation recording means for recording the number of times a user uses said respiratory rescue means.

21. The device of claim 20 wherein said actuation recording means is a separate monitor adapted for use with said rescue means.

22. The device of claim 20 wherein said actuation recording means is an actuation monitor integrally connected to said rescue means.

23. The device of claim 19 wherein said controller means includes at least a first controller medication and a second controller medication.

24. The device of claim 19 wherein said long-term controller medication is selected from the group consisting of inhaled corticosteroids, long-acting bronchodilators, and leukotriene modifiers.

25. The device of claim 19 wherein said fast-acting rescue medication is albuterol.